Amanote Research
Register
Sign In
AB0401 the Efficent Regulation of Tocilizumab for the Expression of CD4+/CD8+ T/Cd19 + B Cells and the Immunoglobulin in Systemic Juvenile Idiopathic Arthritis
doi 10.1136/annrheumdis-2017-eular.2114
Full Text
Open PDF
Abstract
Available in
full text
Date
June 1, 2017
Authors
H Li
H Zeng
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism
Related search
A History Case of Tocilizumab Usage in a Patient With Systemic Juvenile Idiopathic Arthritis
Voprosy Sovremennoi Pediatrii - Current Pediatrics
Child Health
Pediatrics
Perinatology
Systemic Juvenile Idiopathic Arthritis in the Republic of Bashkortostan
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Tocilizumab
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
Myositis in the Course of the Systemic Form Juvenile Idiopathic Arthritis
Reumatologia
Rheumatology
Allergy
Immunology
Autoimmune Arthritis Induces Paired Immunoglobulin-Like Receptor B Expression on CD4+ T Cells From SKG Mice
European Journal of Immunology
Allergy
Immunology
Tocilizumab for Juvenile Idiopathic Arthritis: A Single-Center Case Series
Sao Paulo Medical Journal
Medicine
389 Chromatin Accessibility Signatures in Human Blood CD4+ T and CD19+ B Cells
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Whole Exome Sequencing in Systemic Juvenile Idiopathic Arthritis
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
The Turnover of Synovial T Cells Is Higher Than in T Cells in the Peripheral Blood in Persistent Oligoarticular Juvenile Idiopathic Arthritis
Rheumatology International
Rheumatology
Allergy
Immunology
